Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lakhani

Showing results (221-230 of 311) with videos related to

Pageof 32
Sort By:
Oncogene|December 7, 2010
Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kitC E Smart, A Wronski, J D French, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomasJorge Sergio Reis-Filho, Pete T Simpson, Nicholas C Turner, et al.
Plos One|June 11, 2013
In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneityChanel E Smart, Brian J Morrison, Jodi M Saunus, et al.
British Journal of Cancer|October 7, 2020
The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrenceRoy Rabbie, Peter Ferguson, Kim Wong, et al.
JCI Insight|March 5, 2019
Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancerAdrian P Wiegmans, Jodi M Saunus, Sunyoung Ham, et al.
Histopathology|March 5, 2024
A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR)Veerle Bossuyt, Elena Provenzano, W Fraser Symmans, et al.
EMBO Molecular Medicine|August 16, 2018
CEP55 is a determinant of cell fate during perturbed mitosis in breast cancerMurugan Kalimutho, Debottam Sinha, Jessie Jeffery, et al.
Journal of Clinical Pathology|March 27, 2012
Observer agreement comparing the use of virtual slides with glass slides in the pathology review component of the POSH breast cancer cohort studyEmily Clare Shaw, Andrew M Hanby, Kevin Wheeler, et al.
Plos One|May 14, 2015
Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using GefitinibDarrell C Bessette, Erik Tilch, Tatjana Seidens, et al.
RNA (New York, N.Y.)|April 5, 2011
SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancerMarjan E Askarian-Amiri, Joanna Crawford, Juliet D French, et al.
Pageof 32

Showing results (221-230 of 311) with videos related to

Sort By:
Pageof 32
Oncogene|December 7, 2010
Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kitC E Smart, A Wronski, J D French, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomasJorge Sergio Reis-Filho, Pete T Simpson, Nicholas C Turner, et al.
Plos One|June 11, 2013
In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneityChanel E Smart, Brian J Morrison, Jodi M Saunus, et al.
British Journal of Cancer|October 7, 2020
The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrenceRoy Rabbie, Peter Ferguson, Kim Wong, et al.
JCI Insight|March 5, 2019
Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancerAdrian P Wiegmans, Jodi M Saunus, Sunyoung Ham, et al.
Histopathology|March 5, 2024
A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR)Veerle Bossuyt, Elena Provenzano, W Fraser Symmans, et al.
EMBO Molecular Medicine|August 16, 2018
CEP55 is a determinant of cell fate during perturbed mitosis in breast cancerMurugan Kalimutho, Debottam Sinha, Jessie Jeffery, et al.
Journal of Clinical Pathology|March 27, 2012
Observer agreement comparing the use of virtual slides with glass slides in the pathology review component of the POSH breast cancer cohort studyEmily Clare Shaw, Andrew M Hanby, Kevin Wheeler, et al.
Plos One|May 14, 2015
Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using GefitinibDarrell C Bessette, Erik Tilch, Tatjana Seidens, et al.
RNA (New York, N.Y.)|April 5, 2011
SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancerMarjan E Askarian-Amiri, Joanna Crawford, Juliet D French, et al.
Pageof 32